A detailed history of Claret Asset Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Claret Asset Management Corp holds 120,619 shares of PFE stock, worth $3.18 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
120,619
Previous 121,508 0.73%
Holding current value
$3.18 Million
Previous $3.4 Million 2.68%
% of portfolio
0.57%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $24,625 - $27,905
-889 Reduced 0.73%
120,619 $3.49 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $44,078 - $51,652
-1,745 Reduced 1.42%
121,508 $3.4 Million
Q1 2024

Apr 29, 2024

BUY
$25.89 - $29.73 $759,949 - $872,664
29,353 Added 31.26%
123,253 $3.42 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $2.24 Million - $2.92 Million
85,911 Added 1075.37%
93,900 $2.7 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $16,815 - $19,655
524 Added 7.02%
7,989 $265,000
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $6,754 - $7,814
187 Added 2.57%
7,465 $274,000
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $1,969 - $2,564
50 Added 0.69%
7,278 $297,000
Q4 2022

Feb 07, 2023

BUY
$41.75 - $54.5 $8,725 - $11,390
209 Added 2.98%
7,228 $370,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $24,068 - $29,381
550 Added 8.5%
7,019 $307,000
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $3,396 - $4,027
-73 Reduced 1.12%
6,469 $339,000
Q1 2022

Apr 04, 2022

BUY
$45.75 - $56.69 $15,051 - $18,651
329 Added 5.3%
6,542 $339,000
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $8,470 - $12,556
-205 Reduced 3.19%
6,213 $367,000
Q3 2021

Dec 02, 2021

SELL
$39.25 - $50.42 $142,752 - $183,377
-3,637 Reduced 36.17%
6,418 $276,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $1,256 - $1,423
35 Added 0.35%
10,055 $394,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $25,050 - $28,251
-748 Reduced 6.95%
10,020 $363,000
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $1.43 Million - $1.82 Million
-42,646 Reduced 79.84%
10,768 $396,000
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $15,875 - $18,625
-500 Reduced 0.93%
53,414 $1.96 Million
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $115,811 - $140,496
3,845 Added 7.68%
53,914 $1.76 Million
Q1 2020

Apr 06, 2020

BUY
$27.03 - $38.62 $279,219 - $398,944
10,330 Added 25.99%
50,069 $1.63 Million
Q4 2019

Jan 07, 2020

SELL
$32.92 - $37.36 $23,076 - $26,189
-701 Reduced 1.73%
39,739 $1.56 Million
Q3 2019

Oct 11, 2019

SELL
$32.49 - $42.13 $4,418 - $5,729
-136 Reduced 0.34%
40,440 $1.45 Million
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $3,439 - $3,861
-93 Reduced 0.23%
40,576 $1.76 Million
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $15,937 - $17,510
-425 Reduced 1.03%
40,669 $1.73 Million
Q4 2018

Feb 07, 2019

SELL
$38.47 - $43.86 $38,931 - $44,386
-1,012 Reduced 2.4%
41,094 $1.79 Million
Q3 2018

Oct 30, 2018

BUY
$34.47 - $41.81 $44,673 - $54,185
1,296 Added 3.18%
42,106 $1.86 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $33,507 - $35,722
-1,016 Reduced 2.43%
40,810 $1.48 Million
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $446 - $518
-14 Reduced 0.03%
41,826 $1.48 Million
Q4 2017

Mar 27, 2018

BUY
$33.26 - $35.29 $1.39 Million - $1.48 Million
41,840
41,840 $1.52 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.